Hormuz Turmoil, Arms Sale Boost LMT Demand Outlook, But Cash Conversion Concerns Persist

What happened

The article highlights that the administration's Project Freedom and $8.6B arms sale create significant tailwinds for Lockheed Martin, with contracts bypassing congressional review and cementing a multi-year revenue pipeline. However, the DeepValue report reveals that Q1 free cash flow was negative $291 million, backlog fell $7.2B to $186.4B, and Aeronautics recorded $210M in unfavorable profit adjustments. While munitions ramps (PAC-3, PrSM) are real, they remain gated by contract definitization and customer acceptance, as management explicitly notes. The stock, trading at 24.7x P/E, already discounts a return to management's FY26 FCF guide of $6.5-6.8B, yet Q1 showed no cash conversion progress. Thus, the investment case still hinges on observable execution improvement, not demand headlines.

Implication

The bullish demand narrative from the Hormuz escalation and arms sales is real but will take quarters to flow through to financials. Lockheed's multi-year outlook is strong, but near-term headwinds from fixed-price losses and working capital drag limit upside. The stock is only attractive near the $480 entry point per the report, with a WAIT rating. Key catalysts are sequential reduction in Aeronautics unfavorable adjustments and definitization of the $4.7B PAC-3 UCA. Until cash conversion normalizes and backlog stabilizes, the risk/reward is balanced but not compelling. The highest-signal checkpoints are Q2 2026 filings and the next earnings call.

Thesis delta

The news reinforces the bullish long-term demand backdrop but does not alter the near-term execution-focused thesis. The fundamental shift would require evidence that cash conversion is improving, not just headlines about demand. Therefore, the WAIT rating remains appropriate, with the same trim above $590 and attractive entry below $480.